ANEUVO CEO Yi-Kai Lo to Present at Unite 2 Fight for Paralysis

Company Profile will Highlight Spinal Stimulation Strategies

Los Angeles, California, October 12, 2021– ANEUVO today announced that Yi-Kai Lo, the company’s co-founder and CEO, will present at the 16th Annual Science & Advocacy Symposium organized by Unite 2 Fight Paralysis (U2FP).

The symposium is “a collaborative gathering that prioritizes the voice of the Spinal Cord Injury (SCI) Community, bringing together research scientists, clinicians, and community advocates, along with investors and industry leaders to exchange information and strategies for achieving recovery from SCI.” The event takes place Thursday, October 21, through Saturday, October 23, 2021.

Mr. Lo’s presentation, “A Journey Toward Commercialization – Restoring Functions After SCI,” takes place on Saturday, October 23, at 1:05 pm. Following the presentation, Mr. Lo will participate in a panel discussion hosted by Matthew Rodreick of U2FP, including Dr. Keith E. Tansey of the Methodist Rehabilitation Center and Dr. Uzma Samadani, of the University of Minnesota.

For more information about the conference, visit U2FP at

About ANEUVO: ANEUVO is a technology and therapy development company dedicated to developing a revolutionary bioelectronic medicines platform to treat diseases and injuries otherwise incurable through conventional approaches.

About Unite 2 Fight Paralysis: Unite 2 Fight Paralysis exists to unite and empower the international spinal cord injury community to cure paralysis through advocacy, education, and support for research. Get Educated and Get Involved.